Abstract
A new HPLC method have been developed and validated for simultaneous determination of carprofen, vitamin B1, B6 and B12 in veterinary pharmaceutical preparations medicines. The method used a Hypersil GOLD aQ (250 x 4.6 mm, 5 µm) column, under the following chromatographic conditions: gradient elution, using a mobile phase composed by phosphate buffer (pH 2.65) and methanol as an organic modifier. The mobile phase was delivered at a flow rate of 1 mL/min and the detection was made by photodiode array (PDA) detector at 292 nm. This method was fully validated and applied on available pharmaceutical product. The limit of detection (LOD) and limit of quantitation (LOQ) for vitamin B1 were 0.5ng/mL and 1.5ng/mL respectively while for vitamin B12 were 1ng/mL and 5ng/mL respectively The main advantages of this HPLC method relies on the possibility to asses in a single run all the above mentioned drugs.
Keywords: Carprofen, vitamin B1, B6 and B12, HPLC, pharmaceutical analysis
Current Analytical Chemistry
Title:Determination of Carprofen in the Presence of some Hydrosoluble Vitamins of Group B by HPLC Method
Volume: 11 Issue: 4
Author(s): Georgeta-Simona Stan, Bianca Elena Mitoi, Andrei Mihaila, Irinel Adriana Badea and Hassan Y. Aboul-Enein
Affiliation:
Keywords: Carprofen, vitamin B1, B6 and B12, HPLC, pharmaceutical analysis
Abstract: A new HPLC method have been developed and validated for simultaneous determination of carprofen, vitamin B1, B6 and B12 in veterinary pharmaceutical preparations medicines. The method used a Hypersil GOLD aQ (250 x 4.6 mm, 5 µm) column, under the following chromatographic conditions: gradient elution, using a mobile phase composed by phosphate buffer (pH 2.65) and methanol as an organic modifier. The mobile phase was delivered at a flow rate of 1 mL/min and the detection was made by photodiode array (PDA) detector at 292 nm. This method was fully validated and applied on available pharmaceutical product. The limit of detection (LOD) and limit of quantitation (LOQ) for vitamin B1 were 0.5ng/mL and 1.5ng/mL respectively while for vitamin B12 were 1ng/mL and 5ng/mL respectively The main advantages of this HPLC method relies on the possibility to asses in a single run all the above mentioned drugs.
Export Options
About this article
Cite this article as:
Stan Georgeta-Simona, Mitoi Elena Bianca, Mihaila Andrei, Badea Adriana Irinel and Aboul-Enein Y. Hassan, Determination of Carprofen in the Presence of some Hydrosoluble Vitamins of Group B by HPLC Method, Current Analytical Chemistry 2015; 11 (4) . https://dx.doi.org/10.2174/1573411011666150326001707
DOI https://dx.doi.org/10.2174/1573411011666150326001707 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
GPR30 Forms an Integral Part of E2-Protective Pathway in Experimental Autoimmune Encephalomyelitis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Novel S-Nitrosothiols Have Potential Therapeutic Uses for Cystic Fibrosis
Current Pharmaceutical Design Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine
Current Medicinal Chemistry EDHF and Gap Junctions: Important Regulators of Vascular Tone Within the Microcirculation
Current Pharmaceutical Biotechnology Editorial (Thematic Issue Cells and Gene Therapy - “Do You Like Green Eggs and Ham?”)
Current Gene Therapy Co-Evolution of Insect Proteases and Plant Protease Inhibitors
Current Protein & Peptide Science Application of dsRNA in Cancer Immunotherapy: Current Status and Future Trends
Anti-Cancer Agents in Medicinal Chemistry Endocrinology and Immunology of Obesity, Obesity Vaccines
Current Clinical Pharmacology Anti-Atherosclerotic Molecules Targeting Oxidative Stress and Inflammation
Current Pharmaceutical Design Celecoxib Upregulates Multidrug Resistance Proteins in Colon Cancer: Lack of Synergy with Standard Chemotherapy
Current Cancer Drug Targets Prospects for Preventative Vaccines Against Prion Diseases
Protein & Peptide Letters Phytocystatins and their Potential to Control Plant Diseases Caused by Fungi
Protein & Peptide Letters Carnosine and Lung Disease
Current Medicinal Chemistry Proteasome Inhibitors Therapeutic Strategies for Cancer
Recent Patents on Anti-Cancer Drug Discovery Alzheimer’s Disease-like Early-phase Brain Pathogenesis: Self-curing Amelioration of Neurodegeneration from Pro-inflammatory ‘Wounding’ to Anti-inflammatory ‘Healing’
Current Alzheimer Research Novel Approaches to Control Biofilm Infections
Current Medicinal Chemistry Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer
Mini-Reviews in Medicinal Chemistry Attacking HIV Provirus: Therapeutic Strategies to Disrupt Persistent Infection
Infectious Disorders - Drug Targets The Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs
Current Drug Targets Hypocalcemia Induced by Raloxifene
Current Drug Safety